Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC).

× No keyword cloud information.

7 in total

Review 1. Advances in small cell bronchogenic carcinoma.

Authors: P A Bunn; M H Cohen; D C Ihde; B E Fossieck; M J Matthews; J D Minna
Journal: Cancer Treat Rep Date: 1977 May-Jun

Review 2. Small-cell carcinoma of the lung: therapeutic management.

Authors: R B Weiss
Journal: Ann Intern Med Date: 1978-04 Impact factor: 25.391

3. Chemotherapy of small cell carcinoma of the lung with V.P. 16-213.

Authors: R D Tucker; A Ferguson; C Van Wyk; R Sealy; R Hewitson; W Levin
Journal: Cancer Date: 1978-05 Impact factor: 6.860

4. The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo.

Authors: B Roswit; M E Patno; R Rapp; A Veinbergs; B Feder; J Stuhlbarg; C B Reid
Journal: Radiology Date: 1968-04 Impact factor: 11.105

Review 5. The role of chemotherapy in the treatment of lung cancer.

Authors: O S Selawry
Journal: Semin Oncol Date: 1974-09 Impact factor: 4.929

6. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.

Authors: J S Sierocki; B S Hilaris; S Hopfan; N Martini; D Barton; R B Golbey; R E Wittes
Journal: Cancer Treat Rep Date: 1979 Sep-Oct

7. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results.

Authors: F Cavalli; W F Jungi; R W Sonntag; N I Nissen; J F Holland
Journal: Cancer Treat Rep Date: 1979 Sep-Oct

7 in total

3 in total

1. Does the substitution of cisplatin in a standard four drug regimen improve survival in small cell carcinoma of the lung? A comparison of two chemotherapy regimens.

Authors: A P Smith; G Anderson; G Chappell; D R Bowen
Journal: Thorax Date: 1991-03 Impact factor: 9.139

2. Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.

Authors: C Collins; C S Higano; R B Livingston; B R Griffin; M D Keppen; T P Miller
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

3. DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2.

Authors: J T Poirier; E E Gardner; N Connis; A L Moreira; E de Stanchina; C L Hann; C M Rudin
Journal: Oncogene Date: 2015-03-09 Impact factor: 9.867

3 in total